
This summary was created by AI, based on 1 opinions in the last 12 months.
Civeo (CVEO-N) has received positive feedback from various experts, highlighting its strong position in the modular housing market across the United States, Canada, and Australia, while being listed in Canada. Analysts note that it is among the cheapest options in this sector, benefiting from a high free cash flow yield derived from its core operations. The company is also actively repurchasing its stock, indicating confidence in its financial performance and commitment to returning value to shareholders. Changes in capital allocation driven by activist members on the board have led to improved operational efficiencies, with the firm positioned to capitalize on the growth associated with LNG Canada Phase 2. This combination of margin expansion and topline growth further solidifies its optimistic outlook, although it currently does not pay a dividend. The average price target set by analysts suggests significant upside potential.
Civeo is a OTC stock, trading under the symbol CVEO (previously CVEO-N on Stockchase) on the undefined (undefined). It is usually referred to as or CVEO
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on CVEO (previously CVEO-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Civeo.
Civeo was recommended as a Top Pick by Andrey Omelchak on 2026-06-26. Read the latest stock experts ratings for Civeo.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Civeo.
Civeo is covered by Stockchase experts and is worth watching.
In the States, Canada, and Australia but listed in Canada. Cheapest modular housing company he's come across. Very high FCF yield from its base business. Buying back all the stock it can. Activist members on board have improved capital allocation tremendously. Direct beneficiaries of LNG Canada Phase 2.
(Analysts’ price target is $35.50)Margin expansion, topline growth. No dividend.